FDA Inspection 1253461 — Holy Cross of Silver Spring Blood Bank

Holy Cross of Silver Spring Blood Bank — FEI 1173166

The FDA completed an inspection of Holy Cross of Silver Spring Blood Bank on October 22, 2024 in Silver Spring, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 22, 2024
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Silver Spring, MD (United States)